Value assessment of NMPA-approved new cancer drugs for solid cancer in China, 2016–2020

BACKGROUND: Whether the high cost of cancer drugs is commensurate with their value to patients, which has become the focus of public concern. We aimed to assess the value of new cancer drugs approved for solid cancer in China and to explore the association between price and value of drugs. METHODS:...

Descripción completa

Detalles Bibliográficos
Autores principales: Luo, Jing, Ou, Shunlong, Wei, Hua, Qin, Xiaoli, Peng, Rui, Wang, Song, Jiang, Qian
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2023
Materias:
Public Health
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9998930/
https://www.ncbi.nlm.nih.gov/pubmed/36908440
http://dx.doi.org/10.3389/fpubh.2023.1109668

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9998930/
https://www.ncbi.nlm.nih.gov/pubmed/36908440
http://dx.doi.org/10.3389/fpubh.2023.1109668

Ejemplares similares